» Articles » PMID: 33968157

Extracellular Vesicle Therapeutics from Plasma and Adipose Tissue

Overview
Journal Nano Today
Specialty Biotechnology
Date 2021 May 10
PMID 33968157
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) are cell-released lipid-bilayer nanoparticles that contain biologically active cargo involved in physiological and pathological intercellular communication. In recent years, the therapeutic potential of EVs has been explored in various disease models. In particular, mesenchymal stromal cell-derived EVs have been shown to exert anti-inflammatory, anti-oxidant, anti-apoptotic, and pro-angiogenic properties in cardiovascular, metabolic and orthopedic conditions. However, a major drawback of EV-based therapeutics is scale-up issues due to extensive cell culture requirements and inefficient isolation protocols. An emerging alternative approach to time-consuming and costly cell culture expansion is to obtain therapeutic EVs directly from the body, for example, from plasma and adipose tissue. This review discusses isolation methods and therapeutic applications of plasma and adipose tissue-derived EVs, highlighting advantages and disadvantages compared to cell culture-derived ones.

Citing Articles

Visceral adipose tissue-derived extracellular vesicles promote stress susceptibility in obese mice via miR-140-5p.

Wang H, Zhang L, Yang W, Ji X, Gao A, Wei Y Acta Pharmacol Sin. 2025; .

PMID: 39930136 DOI: 10.1038/s41401-025-01484-z.


Extracellular vesicles from platelet-poor plasma possess anti-inflammatory and anti-catabolic effects in chondrocytes stimulated with IL-1β or synovial membrane-conditioned media.

Gulova S, Slovinska L, Fecskeova L, Bzdilova J, Matejova J, Moravek M J Orthop Surg Res. 2024; 19(1):847.

PMID: 39702385 PMC: 11657764. DOI: 10.1186/s13018-024-05355-x.


Exosome-based cell therapy for diabetic foot ulcers: Present and prospect.

Yang Z, Yang M, Rui S, Hao W, Wu X, Guo L Heliyon. 2024; 10(20):e39251.

PMID: 39498056 PMC: 11532254. DOI: 10.1016/j.heliyon.2024.e39251.


Hydrogel Microneedle Patches Loaded with Stem Cell Mitochondria-Enriched Microvesicles Boost the Chronic Wound Healing.

Yao W, Zhou J, Tang C, Zhang J, Chen Z, Li Y ACS Nano. 2024; 18(39):26733-26750.

PMID: 39238258 PMC: 11447894. DOI: 10.1021/acsnano.4c06921.


Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy.

Chen Y, Tang S, Cai F, Wan Y Research (Wash D C). 2024; 7:0421.

PMID: 39040921 PMC: 11260559. DOI: 10.34133/research.0421.


References
1.
Reshke R, Taylor J, Savard A, Guo H, Rhym L, Kowalski P . Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone. Nat Biomed Eng. 2020; 4(1):52-68. DOI: 10.1038/s41551-019-0502-4. View

2.
Ibrahim M . Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2009; 11(1):11-8. DOI: 10.1111/j.1467-789X.2009.00623.x. View

3.
Ouchi N, Parker J, Lugus J, Walsh K . Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2):85-97. PMC: 3518031. DOI: 10.1038/nri2921. View

4.
Villeda S, Luo J, Mosher K, Zou B, Britschgi M, Bieri G . The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011; 477(7362):90-4. PMC: 3170097. DOI: 10.1038/nature10357. View

5.
Blazquez R, Sanchez-Margallo F, de la Rosa O, Dalemans W, Alvarez V, Tarazona R . Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol. 2014; 5:556. PMC: 4220146. DOI: 10.3389/fimmu.2014.00556. View